Startoon Labs is a medical devices startup based in Hyderabad, India, that makes Pheezee, a wearable device that tracks muscle activity and joint range of motion for physiotherapy patients.

This Startup Deep Dive explains what Startoon Labs does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Startoon Labs in Brief

• What it is: Startoon Labs is an Indian Rehab medical devices company based in Hyderabad.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Pheezee is a wearable, IoT-enabled physiotherapy assessment device that measures surface electromyogram (sEMG) of bulk muscles and range of motion of primary joints at the same time.
• It tracks range of motion in major joints with one-degree resolution and generates AI-based analytics and clinical reports.
• It tracks recovery after orthopedic and neurological conditions and supports tele-rehabilitation so patients can continue sessions at home while surgeons follow progress.
• Funding: Reports differ: aggregators list roughly $10K to about $465K; first equity round in 2018 was undisclosed.

Startoon Labs Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Startoon Labs?

Startoon Labs operates in the Rehab medical devices space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Startoon Labs.

• Pheezee is a wearable, IoT-enabled physiotherapy assessment device that measures surface electromyogram (sEMG) of bulk muscles and range of motion of primary joints at the same time.
• It tracks range of motion in major joints with one-degree resolution and generates AI-based analytics and clinical reports.
• It tracks recovery after orthopedic and neurological conditions and supports tele-rehabilitation so patients can continue sessions at home while surgeons follow progress.
• Customers are mainly hospitals and rehabilitation centres; patients can also get the device on lease within a physiotherapy package.

The Origin Story of Startoon Labs

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Susurla V S Suresh, Mythreyi Kondapi.
• Founded in November 2017 in Hyderabad by Susurla V S Suresh and Mythreyi Kondapi, a husband-and-wife team of electronics engineers.
• Reports describe them as alumni of IIT-Madras, IIM-Calcutta and IIM-Ahmedabad; Kondapi is co-founder and CTO.
• It began as a product-development company building IoT products and smart electronics in embedded systems and robotics, then focused on Pheezee as a smart physiotherapy toolkit.
• The company was incubated at WE Hub, and reports also cite T-Hub acceleration, IKP Knowledge Park funding and BIRAC support.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Rehab medical devices sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• November 2017: company founded in Hyderabad.
• November 2018: announced its first round of equity funding (amount undisclosed).
• May 2023: Pheezee USFDA clearance announced; one report describes it as 510(k) exempt.
• 2023: Company reported ISO 13485:2016 and ISO 9001:2015 certification and CDSCO registration.
• 2023: Reported in use at more than 50 hospitals across four states, with plans to expand to 10 states.

Startoon Labs Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• November 2018: first equity round, amount and investor not disclosed.
• Investors listed by an aggregator include IKP Knowledge Park, Guptaji Invests and AIC-CCMB; total raised differs widely by source.
• Company planned to raise about Rs 3 crore in a bridge round to expand sales and marketing (reported).

How Does Startoon Labs Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Hardware sales: wearable device priced about Rs 59,000 and a full kit with tablet and printer about Rs 79,000 (reported).
• Patient lease of about Rs 30,000 bundled into a 3-6 month physiotherapy package (reported).
• Additional charges for reports generated from its patient database.

The Numbers: Startoon Labs Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Reports differ: one aggregator shows revenue of about $18K for the year to March 2022, another about Rs 78.9 lakh for FY25; neither is an official filing.

Market Opportunity for Startoon Labs

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• India has only about one lakh physiotherapists, per a company interview, which frames demand for assisted recovery tracking.
• Pheezee targets hospitals, rehab centres and home rehabilitation, with US regulatory clearance opening export potential.

Technology and Product at Startoon Labs

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Wearable sEMG and range-of-motion sensing with Bluetooth connectivity to an app.
• AI-based recovery analytics and clinical reports; patented in India only so far (reported).

Team and Culture at Startoon Labs

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Susurla V S Suresh is founder and CEO; Mythreyi Kondapi is co-founder and CTO.
• Headcount estimates range from about 1 to about 30 depending on aggregator.

Startoon Labs Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Startoon Labs

• Public funding and revenue data are inconsistent and unaudited in sources read.
• Hospital adoption depends on small-clinic budgets; patent protection is Indian only so far (reported).
• Competing with much larger global digital-rehab players.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Startoon Labs Growth Outlook: What to Watch

• Plans to expand to more Indian states and pursue international certification and tele-rehabilitation use.
• Exploring tie-ups with corporate hospitals and pain-management programmes (reported).
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Startoon Labs can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Startoon Labs Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Startoon Labs

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Startoon Labs.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Startoon Labs

Studying a company in the Rehab medical devices space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Startoon Labs.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Startoon Labs as a Startup

• Customer clarity: Can Startoon Labs name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Startoon Labs is part of India’s growing Rehab medical devices ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Startoon Labs FAQs: Frequently Asked Questions

What is Startoon Labs?

Startoon Labs is a medical devices startup based in Hyderabad, India, that makes Pheezee, a wearable device that tracks muscle activity and joint range of motion for physiotherapy patients. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Startoon Labs?

Startoon Labs was founded by Susurla V S Suresh, Mythreyi Kondapi, and the company reports a founding year of 2017.

How much funding has Startoon Labs raised?

Reports differ: aggregators list roughly $10K to about $465K; first equity round in 2018 was undisclosed. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Startoon Labs make money?

Startoon Labs earns revenue from its Rehab medical devices products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Startoon Labs?

Reported rivals include Myomed, Sword Health, Manual goniometer. See the competitor comparison above for how they differ.

What are the main risks for Startoon Labs?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Angel One — Angel One: from 1996 broker to 31M-client listed platform | 32Watts — 32 Watts: Delhi clear-aligner brand with 10,000+ smile treatments, majority-acquired by Rejove in 2023. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.